Hexacheck-US is a specialized IP management firm dedicated to protecting and licensing world-class cardiovascular monitoring technologies. Rooted in deep electrical engineering expertise, we bridge the gap between clinical-grade diagnostic capabilities and wearable convenience.
Current 6-lead ECG solutions require users to carry and retrieve external hardware whenever a measurement is needed. While handheld ECG devices have helped expand access to 6-lead cardiac monitoring, the external-device format can remain a barrier to convenient, anytime-anywhere use.
Today’s leading smartwatches have popularized 1-lead ECG monitoring. However, 1-lead data provides only a partial view and is often insufficient for complex cardiac diagnostics that demand the medical-grade depth of a 6-lead output.
Our patented innovation bridges these two worlds. Integrating just one additional contact point for the left leg transforms standard 1-lead wearable devices into sophisticated 6-lead diagnostic systems. No bulky hardware, no added cost—just clinical-grade monitoring capabilities and advanced medical intelligence.
We significantly reduce the learning curve. Users take the exact same posture already proven and popularized by handheld 6-lead leaders. By maintaining the familiar UX while removing the friction of external devices, we realize the future of continuous, seamless cardiac monitoring technologies.
Engineered with a sophisticated dual-amplifier and three-electrode configuration designed to capture 6-channel ECG signals with minimal noise interference.
Developed to address the physical constraints of wearable sensors, aiming to ensure stable signal acquisition across diverse skin types and conditions.
A specialized circuit and electrode architecture developed to optimize multi-channel signal paths, maximizing data fidelity for advanced cardiac analysis without mechanical complexity.
Hexacheck-US was established to steward a robust portfolio of intellectual property that represents years of breakthrough hardware development.
We firmly believe that true innovation should be protected, respected, and shared through fair and ethical licensing.
Our mission is to ensure that our foundational technologies reach their full potential in the global market,
empowering industry partners and saving lives through accessible cardiac monitoring.
Hexacheck’s ECG-related intellectual property portfolio covers patent-based wearable cardiac monitoring architectures and device concepts.
Connected to Hexacheck Inc., Hexacheck-US is being developed to support the strategic protection, licensing, financing,
and commercialization of these technologies in collaboration with qualified partners.
Led by a pioneering inventor with an extensive background in Electrical Engineering and Biosignal Processing,
Hexacheck’s core technology was born from an obsession with accuracy.
Our founder holds numerous foundational patents, capturing the precise circuitry required for high-fidelity ECG acquisition in miniature formats.
From Paper to Prototype:
Asserting Real-World Value Hexacheck-US does not manage "paper patents."
Our IP is the actual blueprint for the next generation of wearables, fully verified through functional watch, ring, and clip-on prototypes.
This journey was never about purchasing litigation assets—it was about decades of rigorous R&D dedicated to setting a new,
life-saving standard for global heart health.
Hexacheck-US is being developed as a U.S.-focused intellectual property and strategic partnership platform connected to HexaCheck Inc., a Korean innovation company specializing in patented wearable ECG technologies.
The platform is designed to connect HexaCheck’s original ECG-related intellectual property with global partners in medical devices, IP financing, licensing, legal collaboration, and commercialization. By focusing on the U.S. market, Hexacheck-US aims to support the strategic protection, financing, licensing, and deployment of HexaCheck’s patent-based wearable ECG technologies.
Chul-woo JEON leads HexaCheck Inc. and oversees software development, business strategy, and the strategic development of Hexacheck-US. He holds bachelor’s and master’s degrees in Electronics Engineering from Daejeon University and has been leading HexaCheck Inc. since 2019.
Dr. In-Duk HWANG is the founder and Chief Technology Officer of HexaCheck Inc. He has extensive experience in electronics engineering, semiconductor research, electronic circuits, ECG research, product planning, and patent development. He previously served as a professor of Electronics Engineering at Daejeon University and conducted research as a visiting scholar at IBM Watson Research Center and the University of Wisconsin.
Copyright © 2026 Hexacheck-US - All Rights Reserved.
Powered by GoDaddy